CareCost Estimate
The Infusion Reimbursement Index · Q2 2026 · v2.0

UnitedHealthcare

CareCost Research · Reviewed by Erin Rose

Scorecard

Grade
C
Index (ASP = 100)
100.0
Vs. acquisition
-2.6%
Brand index
100.0
Biosimilar index
104.3
Contract variability
High
Drugs observed
945
States
52

Contracts below the typical acquisition benchmark (102.7) on the median drug.

How this payer prices

On this filing, the median drug carries 47 distinct contracted rates across practices, with 70% of billing volume on the single most common rate — a dispersed, negotiated book. Top-quartile practices contract about 9% above bottom-quartile practices — the negotiated tail favors scale.

Benchmarks: typical acquisition 102.7 · Medicare 104.3 after sequestration · 106 statutory (ASP = 100).

Contracted rates from insurers’ machine-readable files, not amounts paid on a claim.